152 related articles for article (PubMed ID: 28031562)
1. Kidney cancer in 2016: RCC - advances in targeted therapeutics and genomics.
Linehan WM; Ricketts CJ
Nat Rev Urol; 2017 Feb; 14(2):76-78. PubMed ID: 28031562
[No Abstract] [Full Text] [Related]
2. Kidney cancer therapy: new perspectives and avenues.
Alexandrescu DT; Dasanu CA
Expert Opin Pharmacother; 2006 Dec; 7(18):2481-93. PubMed ID: 17150003
[TBL] [Abstract][Full Text] [Related]
3. Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells.
Sutphin PD; Chan DA; Li JM; Turcotte S; Krieg AJ; Giaccia AJ
Cancer Res; 2007 Jun; 67(12):5896-905. PubMed ID: 17575159
[TBL] [Abstract][Full Text] [Related]
4. Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents.
Porta C; Toscani I; Czarnecka AM; Szczylik CA
Expert Opin Biol Ther; 2017 Feb; 17(2):151-162. PubMed ID: 27960591
[TBL] [Abstract][Full Text] [Related]
5. [The introduction of targeted drugs].
Bergmann L; Miller K
Onkologie; 2010; 33 Suppl 1():1. PubMed ID: 20164667
[No Abstract] [Full Text] [Related]
6. Novel therapies for renal cell carcinoma--an update.
Fishman M; Antonia S
Expert Opin Investig Drugs; 2003 Apr; 12(4):593-609. PubMed ID: 12665415
[TBL] [Abstract][Full Text] [Related]
7. Targeting HIF2α in Clear-Cell Renal Cell Carcinoma.
Ricketts CJ; Crooks DR; Linehan WM
Cancer Cell; 2016 Oct; 30(4):515-517. PubMed ID: 27728802
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress?
Rini BI; Bukowski RM
Oncology (Williston Park); 2008 Apr; 22(4):388-96; discussion 396, 402-3, 476 passim. PubMed ID: 18472614
[TBL] [Abstract][Full Text] [Related]
9. [Molecular targeted therapy for renal cell carcinoma].
Mizutani Y; Nakanishi H; Mizuno M; Yoshida J; Miki T
Hinyokika Kiyo; 2008 Jan; 54(1):53-6. PubMed ID: 18260362
[TBL] [Abstract][Full Text] [Related]
10. Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy.
Rustum YM; Chintala S; Durrani FA; Bhattacharya A
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380599
[TBL] [Abstract][Full Text] [Related]
11. Kidney cancer: neoadjuvant targeted therapies in renal cell carcinoma.
Ficarra V; Novara G
Nat Rev Urol; 2010 Feb; 7(2):63-4. PubMed ID: 20145660
[No Abstract] [Full Text] [Related]
12. Successes and limitations of targeted therapies in renal cell carcinoma.
Pracht M; Berthold D
Prog Tumor Res; 2014; 41():98-112. PubMed ID: 24727990
[TBL] [Abstract][Full Text] [Related]
13. Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.
Chapman AE; Goldstein LJ
Semin Oncol; 1995 Feb; 22(1):17-28. PubMed ID: 7855615
[No Abstract] [Full Text] [Related]
14. Emerging drugs for renal cell carcinoma.
Varella L; Rini BI
Expert Opin Emerg Drugs; 2010 Sep; 15(3):343-53. PubMed ID: 20443750
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of renal cell cancer.
Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy and hand-foot skin reaction in advanced renal cell carcinoma.
Yang CH; Chuang CK; Hsieh JJ; Chang JW
Expert Opin Drug Saf; 2010 May; 9(3):459-70. PubMed ID: 20113155
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
18. Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature.
Kakoki K; Miyata Y; Mochizuki Y; Iwata T; Obatake M; Abe K; Nagayasu T; Sakai H
Clin Genitourin Cancer; 2017 Jun; 15(3):e503-e506. PubMed ID: 28190703
[No Abstract] [Full Text] [Related]
19. Exceptional Response to Nivolumab Rechallenge in Metastatic Renal Cell Carcinoma with Parallel Changes in Genomic Profile.
Dizman N; Bergerot P; Bergerot C; Lanman RB; Raymond VM; Banks KC; Jones J; Pal SK
Eur Urol; 2018 Feb; 73(2):308-310. PubMed ID: 28844598
[No Abstract] [Full Text] [Related]
20. Advances in chemotherapy for renal cell carcinoma.
Huben RP
Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
